Lite Strategy Reports First Quarter Fiscal Year 2026 Results; Highlights Successful Launch of $100M Litecoin Treasury Strategy and Movement into Active Capital Market Operations

Core Insights - Lite Strategy, Inc. (NASDAQ: LITS) is the first U.S. publicly traded company to adopt Litecoin (LTC) as its primary reserve asset, holding 929,548 LTC tokens [1][6][7] - The company has launched a digital treasury strategy aimed at providing institutional exposure to Litecoin, enhancing portfolio diversification and long-term value for investors [2][6] - The fiscal year 2026 is expected to reflect the transformative steps taken by the company, including the successful sale of clinical assets and a $100 million PIPE offering [2][4] Financial Highlights - As of September 30, 2025, the company reported $12.21 million in working capital with no outstanding debt [4] - The company raised $100 million in gross proceeds to initiate its long-term strategic plan centered around Litecoin [6] Corporate Developments - The company has rebranded from MEI Pharma to Lite Strategy, reflecting its new focus on digital asset treasury strategies [6][7] - A strategic partnership has been established with GSR, a leading crypto investment firm, to guide the company's digital asset treasury strategy [6] - A $25 million share repurchase program has been announced, allowing the company to leverage its nearly 1 million LTC treasury [6]